Identification of CD244-expressing myeloid-derived suppressor cells in patients with active tuberculosis

Immunology Letters

Volumn 158, Issue 1-2, 2014, Pages 66-72

  Yang, Bingfen ^a   Wang, Xinjing ^a   Jiang, Jing ^a   Zhai, Fei ^a   Cheng, Xiaoxing ^a  

^a 309TH HOSPITAL OF PLA   (China)

Author keywords

CD244; Immunity; Myeloid derived suppressor cells; Tuberculosis

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD15 ANTIGEN; CD19 ANTIGEN; CD244 ANTIGEN; CD3 ANTIGEN; CD33 ANTIGEN; CD56 ANTIGEN; CD66B ANTIGEN; HLA DR ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CD244 PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; NOS2 PROTEIN, HUMAN;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MYELOID DERIVED SUPPRESSOR CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPRESSOR CELL; TUBERCULOSIS; ADAPTIVE IMMUNITY; CELL COUNT; CELL CULTURE; DISEASE COURSE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MYELOID PROGENITOR CELL; TUBERCULOSIS, PULMONARY;

ADAPTIVE IMMUNITY; ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, INNATE; MALE; MYELOID PROGENITOR CELLS; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, IMMUNOLOGIC; TUBERCULOSIS, PULMONARY;

EID: 84890963096     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.12.003     Document Type: Article

References (38)

1. Glaziou P., Falzon D., Floyd K., Raviglione M. Global epidemiology of tuberculosis. Semin Respir Crit Care Med 2013, 34:3-16.
2. Philips J.A., Ernst J.D. Tuberculosis pathogenesis and immunity. Annu Rev Pathol 2012, 7:353-384.
3. Schwander S., Dheda K. Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection. Am J Respir Crit Care Med 2011, 183:696-707.
4. Jurado J.O., Alvarez I.B., Pasquinelli V., Martinez G.J., Quiroga M.F., Abbate E., et al. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 2008, 181:116-125.
5. Lazar-Molnar E., Chen B., Sweeney K.A., Wang E.J., Liu W., Lin J., et al. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis. Proc Natl Acad Sci U S A 2010, 107:13402-13407.
6. Wang X., Cao Z., Jiang J., Li Y., Dong M., Ostrowski M., et al. Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis. J Infect 2011, 62:292-300.
7. Qiu Y., Chen J., Liao H., Zhang Y., Wang H., Li S., et al. Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions. PLoS Pathog 2012, 8:e1002984.
8. Jiang J., Wang X., Wang X., Cao Z., Liu Y., Dong M., et al. Reduced CD27 expression on antigen-specific CD4+ T cells correlates with persistent active tuberculosis. J Clin Immunol 2010, 30:566-573.
9. Sharma P.K., Saha P.K., Singh A., Sharma S.K., Ghosh B., Mitra D.K. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med 2009, 179:1061-1070.
10. Li L., Wu C.Y. CD4+ CD25+ Treg cells inhibit human memory gammadelta T cells to produce IFN-gamma in response to M. tuberculosis antigen ESAT-6. Blood 2008, 111:5629-5636.
11. Chen X., Zhou B., Li M., Deng Q., Wu X., Le X., et al. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 2007, 123:50-59.
12. Hougardy J.M., Place S., Hildebrand M., Drowart A., Debrie A.S., Locht C., et al. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med 2007, 176:409-416.
13. Gabrilovich D.I., Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
14. Tacke R.S., Lee H.C., Goh C., Courtney J., Polyak S.J., Rosen H.R., et al. Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species. Hepatology 2012, 55:343-353.
15. Vollbrecht T., Stirner R., Tufman A., Roider J., Huber R.M., Bogner J.R., et al. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 2012, 26:F31-F37.
16. Diaz-Montero C.M., Salem M.L., Nishimura M.I., Garrett-Mayer E., Cole D.J., Montero A.J. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 2009, 58:49-59.
17. Ostrand-Rosenberg S., Sinha P. Myeloid-derived suppressor cells: linking inflammation and cancer. J Immunol 2009, 182:4499-4506.
18. Martino A., Badell E., Abadie V., Balloy V., Chignard M., Mistou M.Y., et al. Mycobacterium bovis bacillus Calmette-Guerin vaccination mobilizes innate myeloid-derived suppressor cells restraining in vivo T cell priming via IL-1R-dependent nitric oxide production. J Immunol 2010, 184:2038-2047.
19. Talmadge J.E. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin Cancer Res 2007, 13:5243-5248.
20. Jayaraman P., Parikh F., Lopez-Rivera E., Hailemichael Y., Clark A., Ma G., et al. Tumor-expressed inducible nitric oxide synthase controls induction of functional myeloid-derived suppressor cells through modulation of vascular endothelial growth factor release. J Immunol 2012, 188:5365-5376.
21. Lindau D., Gielen P., Kroesen M., Wesseling P., Adema G.J. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology 2013, 138:105-115.
22. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008, 181:5791-5802.
23. Liu C.Y., Wang Y.M., Wang C.L., Feng P.H., Ko H.W., Liu Y.H., et al. Population alterations of l-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14(-)/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer. J Cancer Res Clin Oncol 2010, 136:35-45.
24. Zea A.H., Rodriguez P.C., Atkins M.B., Hernandez C., Signoretti S., Zabaleta J., et al. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 2005, 65:3044-3048.
25. Poschke I., Mougiakakos D., Hansson J., Masucci G.V., Kiessling R. Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign. Cancer Res 2010, 70:4335-4345.
26. du Plessis N., Loebenberg L., Kriel M., von Groote-Bidlingmaier F., Ribechini E., Loxton A.G., et al. Increased frequency of myeloid-derived suppressor cells during active tuberculosis and after recent Mycobacterium tuberculosis infection suppresses T-cell function. Am J Respir Crit Care Med 2013, 188:724-732.
27. Li L., Qiao D., Fu X., Lao S., Zhang X., Wu C. Identification of M. tuberculosis-specific Th1 cells expressing CD69 generated in vivo in pleural fluid cells from patients with tuberculous pleurisy. PLoS ONE 2011, 6:e23700.
28. Avgustin B., Kotnik V., Skoberne M., Malovrh T., Skralovnik-Stern A., Tercelj M. CD69 expression on CD4+ T lymphocytes after in vitro stimulation with tuberculin is an indicator of immune sensitization against Mycobacterium tuberculosis antigens. Clin Diagn Lab Immunol 2005, 12:101-106.
29. Faul F., Erdfelder E., Buchner A., Lang A.G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009, 41:1149-1160.
30. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.
31. Mazzoni A., Bronte V., Visintin A., Spitzer J.H., Apolloni E., Serafini P., et al. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol 2002, 168:689-695.
32. Russell D.G. Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol Rev 2011, 240:252-268.
33. Rohde K., Yates R.M., Purdy G.E., Russell D.G. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev 2007, 219:37-54.
34. Chlewicki L.K., Velikovsky C.A., Balakrishnan V., Mariuzza R.A., Kumar V. Molecular basis of the dual functions of 2B4 (CD244). J Immunol 2008, 180:8159-8167.
35. Raziorrouh B., Schraut W., Gerlach T., Nowack D., Gruner N.H., Ulsenheimer A., et al. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 2010, 52:1934-1947.
36. Blackburn S.D., Shin H., Haining W.N., Zou T., Workman C.J., Polley A., et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009, 10:29-37.
37. Schlaphoff V., Lunemann S., Suneetha P.V., Jaroszewicz J., Grabowski J., Dietz J., et al. Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS Pathog 2011, 7:e1002045.
38. Yang B., Wang X., Jiang J., Cheng X. Involvement of CD244 in regulating CD4+ T cell immunity in patients with active tuberculosis. PLoS ONE 2013, 8:e63261.